Stockreport

FDA grants accelerated review status for Sage Therapeutics' SAGE-217 for MDD [Seeking Alpha]

Sage Therapeutics, Inc.  (SAGE) 
Last sage therapeutics, inc. earnings: 2/27 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.sagerx.com/investor-relations
PDF FDA grants accelerated review status for Sage Therapeutics' SAGE-217 for MDDThe FDAdesignates Sage Therapeutics' (NASDAQ:SAGE) Phase 3-stage SAGE-217 a Breakthrough Ther [Read more]